16.05.2018 22:01:00
|
ViewRay to Present at the UBS Global Healthcare Conference
CLEVELAND, May 16, 2018 /PRNewswire/ -- ViewRay®, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in New York, NY.
Event: | UBS Global Healthcare Conference |
Date: | Tuesday, May 22, 2018 |
Time: | 3:00pm ET |
An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content with multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-ubs-global-healthcare-conference-300648510.html
SOURCE ViewRay, Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ViewRay Incmehr Nachrichten
Keine Nachrichten verfügbar. |